HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Glenmark Pharmaceuticals turns black in Q3
Feb-17-2025

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported net profit at Rs 413.80 crore for Q3FY25 as compared to net loss of Rs 20.41 crore for the same quarter in the previous year. Total income of the company increased by 46.59% at Rs 2380.47 crore for Q3FY25 as compared to Rs 1623.91 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net profit at Rs 347.96 crore for the quarter ended December 31, 2024 as compared to net loss of Rs 351.37 crore for the same quarter in the previous year. Total income of the company increased by 33.96% at Rs 3418.68 crore for Q3FY25 as compared to Rs 2552.11 crore for the corresponding quarter previous year.


  RELATED NEWS >>